HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Koh Furugaki Selected Research
Koh Furugaki Research Topics
Disease
12
Neoplasms (Cancer)
01/2020 - 03/2010
8
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 11/2010
7
Lung Neoplasms (Lung Cancer)
01/2022 - 01/2014
2
Sarcoma (Soft Tissue Sarcoma)
04/2019 - 02/2014
2
Pancreatic Neoplasms (Pancreatic Cancer)
03/2010 - 04/2007
1
Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2019
1
Colorectal Neoplasms (Colorectal Cancer)
02/2014
1
Neoplasm Metastasis (Metastasis)
10/2011
1
Stomach Neoplasms (Stomach Cancer)
08/2011
1
Breast Neoplasms (Breast Cancer)
08/2010
1
Hepatocellular Carcinoma (Hepatoma)
01/2009
Drug/Important Bio-Agent (IBA)
8
ErbB Receptors (EGF Receptor)
IBA
04/2019 - 08/2011
6
Tyrosine Kinase Inhibitors
IBA
01/2022 - 10/2011
5
alectinib
IBA
01/2022 - 01/2019
5
Anaplastic Lymphoma Kinase
IBA
01/2022 - 01/2019
5
Erlotinib Hydrochloride (CP 358,774)
FDA Link
08/2017 - 03/2010
3
Bevacizumab (Avastin)
FDA Link
08/2017 - 08/2010
2
Proteins (Proteins, Gene)
FDA Link
01/2020 - 04/2019
2
Pharmaceutical Preparations
IBA
01/2019 - 02/2016
2
Antibodies
IBA
08/2011 - 01/2009
1
Apoptosis Regulatory Proteins
IBA
01/2020
1
Cyclin-Dependent Kinase 4
IBA
01/2020
1
ATP-Binding Cassette Transporters (ABC Transporters)
IBA
01/2020
1
Messenger RNA (mRNA)
IBA
04/2019
1
Biomarkers (Surrogate Marker)
IBA
04/2019
1
Ado-Trastuzumab Emtansine
IBA
01/2019
1
src-Family Kinases
IBA
01/2019
1
Crizotinib
IBA
01/2019
1
saracatinib
IBA
01/2019
1
human ERBB2 protein
IBA
01/2019
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
08/2017
1
B7-H1 Antigen
IBA
01/2017
1
Codon (Codons)
IBA
02/2014
1
DNA (Deoxyribonucleic Acid)
IBA
02/2014
1
Trastuzumab (Herceptin)
FDA Link
08/2011
1
pertuzumab
IBA
08/2011
1
Docetaxel (Taxotere)
FDA Link
11/2010
1
Paclitaxel (Taxol)
FDA Link
Generic
08/2010
1
Gemcitabine
FDA Link
03/2010
1
Glypicans
IBA
01/2009
1
Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)
IBA
01/2009
1
Complement System Proteins (Complement)
IBA
04/2007
Therapy/Procedure
7
Therapeutics
01/2022 - 03/2010
1
Immunotherapy
01/2017